Continuous glucose monitoring (CGM) is now the standard of care for people with type 1 diabetes in many countries, but its role in the management of type 2 diabetes is less well established. This is ...

Many patients taking glucagon-like peptide-1 (GLP-1) receptor agonists have reported psychological benefits alongside reduced ...

Drugmakers continue to test weight-loss medicines against dummy pills and shots, even with a growing number of effective approved obesity drugs. This practice raises practical questions.

Can weight-loss drugs like semaglutide prevent Alzheimer's? New research reveals GLP-1 drugs reduce amyloid and tau proteins ...

Two new studies show that tirzepatide, a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like ...

Retatrutide shows big weight loss potential but isn’t FDA-approved. Here’s what to know about its safety and legal risks.

People taking GLP-1s had reduced risk for atrial fibrillation, regardless of whether they lost weight or how much they lost, ...

HCM causes the heart muscle to abnormally thicken, making it harder for the heart to pump blood effectively. According to the ...

A phase 3 trial has shown efficacy in type 2 diabetes for adolescents, positioning it as a potential first oral solution for ...

MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel precision peptide therapies for the treatment of ...

The rise of GLP-1 receptor agonists such as Mounjaro and Ozempic, combined with the rise of “on-the-go” consumption habits ...

High-dose tirzepatide is associated with superior HbA1c reduction and weight loss compared with semaglutide in type 2 ...